Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3

Topic: Disease mechanisms in lab and animal studies

During Alzheimer's (AD), tau protein suffers from abnormal post-translational modifications, including cleaving by caspase-3. These tau forms affect synaptic plasticity contributing to the cognitive decline observed in the early stages of AD. In addition, caspase-3 cleaved tau (TauC3) impairs mitochondrial dynamics and organelles transport, which are both relevant processes for synapse. We recently showed that the absence of tau expression reverts age-associated cognitive and mitochondrial failure by blocking the mitochondrial permeability transition pore (mPTP). mPTP is a mitochondrial complex involved in calcium regulation and apoptosis. Therefore, we studied the effects of TauC3 against the dendritic spine and synaptic vesicle formation and the possible role of mPTP in these alterations. We used mature hippocampal mice neurons to express a reporter protein (GFP, mCherry), coupled to full-length human tau protein (GFP-T4, mCherry-T4), and coupled to human tau protein cleaved at D421 by caspase-3 (GFP-T4C3, mCherry-T4C3) and synaptic elements were evaluated. Treatment with cyclosporine A (CsA), an immunosuppressive drug with inhibitory activity on mPTP, prevented ROS increase and mitochondrial depolarization induced by TauC3 in hippocampal neurons. These results were corroborated with immortalized cortical neurons in which ROS increase and ATP loss induced by this tau form were prevented by CsA. Interestingly, TauC3 expression significantly reduced dendritic spine density (filopodia type) and synaptic vesicle number in hippocampal neurons. Also, neurons transfected with TauC3 showed a significant accumulation of synaptophysin protein in their soma. More importantly, all these synaptic alterations were prevented by CsA, suggesting an mPTP role in these negative changes derived from TauC3 expression.

Key findings

• We recently showed that the absence of tau expression reverts age-associated cognitive and mitochondrial failure by blocking the mitochondrial permeability transition pore (mPTP). mPTP is a mitochondrial complex involved in calcium regulation and apoptosis.
• These results were corroborated with immortalized cortical neurons in which ROS increase and ATP loss induced by this tau form were prevented by CsA.
• Interestingly, TauC3 expression significantly reduced dendritic spine density (filopodia type) and synaptic vesicle number in hippocampal neurons.
• Also, neurons transfected with TauC3 showed a significant accumulation of synaptophysin protein in their soma.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/j.mcn.2023.103861
• PubMed: 37182572
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{tapiamonsalves2023-37182572,
  author  = {Tapia-Monsalves, Carola and Olesen, Margrethe A and Villavicencio-Tejo, Francisca and Quintanilla, Rodrigo A},
  title   = {{Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3}},
  journal = {Molecular and cellular neurosciences},
  year    = {2023},
  doi     = {10.1016/j.mcn.2023.103861},
  pmid    = {37182572},
  url     = {https://doi.org/10.1016/j.mcn.2023.103861}
}

Related studies in Disease mechanisms

• Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers Annals of neurology · 2006-12-01 · usefulness score 40/100
• Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway Journal of Neuroscience · 2009-11-25 · usefulness score 40/100
• Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies Frontiers in Medicine · 2025-05-14 · usefulness score 34/100
• Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease Nature neuroscience · 2010-12-12 · usefulness score 40/100
• ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures The Journal of biological chemistry · 2006-05-18 · usefulness score 36/100
• Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis Neuron · 2015-09-01 · usefulness score 36/100

Also tagged “phosphorylation”

387 studies in the library carry the topic tag “phosphorylation”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 387 tagged studies.

• The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America · 1997-06-01 · usefulness score 36/100 · Drug development
• Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease ACS nano · 2018-02-01 · usefulness score 38/100 · Drug development
• Cell-death pathways and tau-associated neuronal vulnerability in Alzheimer's disease Cell reports · 2025-05-29 · usefulness score 43/100 · Genetics

Similar studies

• The role of pathological tau in synaptic dysfunction in Alzheimer's diseases 2021 · Disease mechanisms
• Soluble pathogenic tau transmission to astrocytes drives cellular senescence and neurovascular uncoupling in a model of Alzheimer’s tauopathy 2026 · Disease mechanisms
• Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice 2011 · Disease mechanisms
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration 2010 · Disease mechanisms
• Transcriptomic Analysis in the Hippocampus and Retina of Tg2576 AD Mice Reveals Defective Mitochondrial Oxidative Phosphorylation and Recovery by Tau 12A12mAb Treatment 2023 · Drug development
• Roles of tau protein in health and disease 2017 · Disease mechanisms

More on Disease mechanisms

• A review that covers this ground The β-adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease Journal of neurochemistry · 2023-02-28 · usefulness score 41/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →